Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Free Cash Flow (2016 - 2026)

Protara Therapeutics' Free Cash Flow history spans 14 years, with the latest figure at -$21.3 million for Q1 2026.

  • Quarterly Free Cash Flow fell 44.63% to -$21.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$63.0 million through Mar 2026, down 56.85% year-over-year, with the annual reading at -$56.5 million for FY2025, 57.39% down from the prior year.
  • Free Cash Flow came in at -$21.3 million for Q1 2026, down from -$17.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$5.0 million in Q4 2022 to a low of -$21.3 million in Q1 2026.
  • The 5-year median for Free Cash Flow is -$9.4 million (2023), against an average of -$10.5 million.
  • Year-over-year, Free Cash Flow soared 47.52% in 2022 and then crashed 82.97% in 2023.
  • Protara Therapeutics' Free Cash Flow stood at -$5.0 million in 2022, then tumbled by 72.89% to -$8.7 million in 2023, then fell by 6.99% to -$9.3 million in 2024, then tumbled by 82.36% to -$17.0 million in 2025, then decreased by 25.74% to -$21.3 million in 2026.
  • Per Business Quant, the three most recent readings for TARA's Free Cash Flow are -$21.3 million (Q1 2026), -$17.0 million (Q4 2025), and -$12.5 million (Q3 2025).